| Primary |
| Depression |
37.3% |
| Product Used For Unknown Indication |
25.7% |
| Major Depression |
5.0% |
| Obsessive-compulsive Disorder |
4.8% |
| Anxiety |
4.6% |
| Drug Use For Unknown Indication |
2.9% |
| Bipolar Disorder |
2.6% |
| Pain |
2.6% |
| Insomnia |
1.9% |
| Postpartum Depression |
1.9% |
| Prophylaxis Of Neural Tube Defect |
1.4% |
| Schizophrenia |
1.4% |
| Decreased Appetite |
1.2% |
| Epilepsy |
1.2% |
| Anaemia |
1.0% |
| Cardiac Disorder |
1.0% |
| Migraine |
1.0% |
| Pyrexia |
1.0% |
| Affective Disorder |
0.7% |
| Antiemetic Supportive Care |
0.7% |
|
| Drug Abuse |
13.6% |
| Toxicity To Various Agents |
7.5% |
| Serotonin Syndrome |
6.8% |
| Suicidal Ideation |
6.8% |
| Death |
6.1% |
| Drug Interaction |
5.4% |
| Completed Suicide |
4.8% |
| Suicide Attempt |
4.8% |
| Tremor |
4.8% |
| Maternal Exposure During Pregnancy |
4.1% |
| Pulmonary Congestion |
4.1% |
| Syncope |
4.1% |
| Cardio-respiratory Arrest |
3.4% |
| Drug Exposure During Pregnancy |
3.4% |
| Drug Ineffective |
3.4% |
| Loss Of Consciousness |
3.4% |
| Overdose |
3.4% |
| Premature Baby |
3.4% |
| Product Substitution Issue |
3.4% |
| Urinary Tract Infection |
3.4% |
|
| Secondary |
| Product Used For Unknown Indication |
29.5% |
| Drug Use For Unknown Indication |
16.3% |
| Depression |
13.7% |
| Anxiety |
6.6% |
| Pain |
5.0% |
| Hypertension |
4.7% |
| Tic |
4.7% |
| Drug Exposure During Pregnancy |
3.2% |
| Tourette's Disorder |
2.4% |
| Major Depression |
2.1% |
| Toxicity To Various Agents |
1.6% |
| Asthma |
1.4% |
| Insomnia |
1.4% |
| Bipolar Disorder |
1.2% |
| Decreased Appetite |
1.2% |
| Myelitis Transverse |
1.2% |
| Muscle Spasms |
1.1% |
| Blood Cholesterol Increased |
1.0% |
| Ovarian Cancer |
1.0% |
| Diabetes Mellitus |
0.9% |
|
| Suicide Attempt |
16.3% |
| Completed Suicide |
14.2% |
| Respiratory Arrest |
5.7% |
| Toxicity To Various Agents |
5.7% |
| Weight Increased |
5.7% |
| Pulmonary Fibrosis |
5.0% |
| Suicidal Ideation |
5.0% |
| Vestibular Disorder |
5.0% |
| Somnolence |
4.3% |
| Vomiting |
4.3% |
| Weight Decreased |
4.3% |
| Maternal Exposure During Pregnancy |
3.5% |
| Serotonin Syndrome |
3.5% |
| Tremor |
3.5% |
| Drug Interaction |
2.8% |
| Extrapyramidal Disorder |
2.8% |
| Cytolytic Hepatitis |
2.1% |
| Drug Exposure During Pregnancy |
2.1% |
| Drug Toxicity |
2.1% |
| Drug Withdrawal Syndrome |
2.1% |
|
| Concomitant |
| Drug Use For Unknown Indication |
29.5% |
| Product Used For Unknown Indication |
16.0% |
| Depression |
11.3% |
| Rheumatoid Arthritis |
8.0% |
| Hypertension |
5.4% |
| Pain |
5.2% |
| Anxiety |
3.1% |
| Crohn's Disease |
2.6% |
| Hiv Infection |
2.3% |
| Gastrooesophageal Reflux Disease |
2.1% |
| Multiple Sclerosis |
2.0% |
| Diabetes Mellitus |
1.6% |
| Prophylaxis |
1.6% |
| Contraception |
1.5% |
| Osteoporosis |
1.4% |
| Nausea |
1.3% |
| Psoriasis |
1.3% |
| Smoking Cessation Therapy |
1.3% |
| Bipolar Disorder |
1.2% |
| Blood Cholesterol Increased |
1.2% |
|
| Vomiting |
10.2% |
| Tremor |
7.6% |
| Weight Increased |
7.1% |
| Weight Decreased |
6.7% |
| Death |
5.8% |
| Pneumonia |
5.3% |
| Pain |
4.9% |
| Suicidal Ideation |
4.9% |
| Granulocytopenia |
4.4% |
| Somnolence |
4.4% |
| Visual Impairment |
4.4% |
| Drug Ineffective |
4.0% |
| Headache |
4.0% |
| Myocardial Infarction |
4.0% |
| Nausea |
4.0% |
| Overdose |
4.0% |
| Urticaria |
4.0% |
| Vitreous Floaters |
3.6% |
| Wheezing |
3.6% |
| Injection Site Pain |
3.1% |
|
| Interacting |
| Product Used For Unknown Indication |
30.9% |
| Depression |
12.7% |
| Anorexia Nervosa |
10.9% |
| Anxiety |
10.9% |
| Back Disorder |
3.6% |
| Bipolar I Disorder |
3.6% |
| Depressive Symptom |
3.6% |
| Drug Use For Unknown Indication |
3.6% |
| Hypertension |
3.6% |
| Psychotic Disorder |
3.6% |
| Bulimia Nervosa |
1.8% |
| Drug Abuse |
1.8% |
| Hypothyroidism |
1.8% |
| Migraine |
1.8% |
| Schizophrenia |
1.8% |
| Tic |
1.8% |
| Tourette's Disorder |
1.8% |
|
| Electrocardiogram Qt Prolonged |
15.8% |
| Intentional Overdose |
15.8% |
| Off Label Use |
15.8% |
| Serotonin Syndrome |
15.8% |
| Affective Disorder |
5.3% |
| Drug Interaction |
5.3% |
| Dysphoria |
5.3% |
| Suicidal Ideation |
5.3% |
| Toxicity To Various Agents |
5.3% |
| Weight Bearing Difficulty |
5.3% |
| Weight Increased |
5.3% |
|
